On ١٠ نوفمبر ٢٠٢٥, RNA reported earnings of -1.27 USD per share (EPS) for Q3 25, missing the estimate of -1.11 USD, resulting in a -14.20% surprise. Revenue reached 12.47 مليون, compared to an expected 1.95 مليون, with a 539.26% difference. The market reacted with a +1.23% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of -1.26 USD, with revenue projected to reach 3.05 مليون USD, implying an decrease of -0.79% EPS, and decrease of -75.58% in Revenue from the last quarter.